| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0021-9150(02)00305-2 |
| P698 | PubMed publication ID | 12417276 |
| P2093 | author name string | W Timothy Garvey | |
| Maria F Lopes-Virella | |||
| Nanlan Luo | |||
| Yuchang Fu | |||
| P2860 | cites work | Regulation of adipocyte gene expression by polyunsaturated fatty acids | Q77582017 |
| Human adipocyte lipid-binding protein: purification of the protein and cloning of its complementary DNA | Q24297507 | ||
| Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma | Q24311702 | ||
| PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL | Q24311741 | ||
| Adipocyte-specific transcription factor ARF6 is a heterodimeric complex of two nuclear hormone receptors, PPAR gamma and RXR alpha | Q24631304 | ||
| PPARγ Is Required for the Differentiation of Adipose Tissue In Vivo and In Vitro | Q28146187 | ||
| Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis | Q28198287 | ||
| Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition | Q28625661 | ||
| The pathogenesis of atherosclerosis: a perspective for the 1990s | Q29547827 | ||
| Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor | Q29547912 | ||
| mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer | Q29617271 | ||
| PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway | Q31793810 | ||
| Adipocyte P2 gene: developmental expression and homology of 5'-flanking sequences among fat cell-specific genes | Q35608025 | ||
| 15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway. | Q35698498 | ||
| Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages | Q36364861 | ||
| Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein | Q36501176 | ||
| Combinatorial interactions between AP-1 and ets domain proteins contribute to the developmental regulation of the macrophage scavenger receptor gene | Q36648885 | ||
| Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice | Q37242527 | ||
| The human leukemia cell line, THP-1: a multifacetted model for the study of monocyte-macrophage differentiation | Q37648485 | ||
| Regulation of ferritin light chain gene expression by oxidized low-density lipoproteins in human monocytic THP-1 cells | Q40918209 | ||
| PPARgamma activation induces the expression of the adipocyte fatty acid binding protein gene in human monocytes | Q40939045 | ||
| Peroxisome proliferator-activated receptors: a nuclear receptor signaling pathway in lipid physiology | Q41275255 | ||
| Low density lipoprotein oxidation and its pathobiological significance | Q41566828 | ||
| Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells | Q42464570 | ||
| Interleukin 8 is induced by cholesterol loading of macrophages and expressed by macrophage foam cells in human atheroma | Q42517095 | ||
| Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein | Q45293298 | ||
| Peroxisome proliferator-activated receptor (PPAR) agonists decrease lipoprotein lipase secretion and glycated LDL uptake by human macrophages | Q45711444 | ||
| The scavenger cell pathway for lipoprotein degradation: Specificity of the binding site that mediates the uptake of negatively-charged LDL by macrophages | Q50337495 | ||
| Thiazolidinediones: an update. | Q54055332 | ||
| Continuous monitoring of in vitro oxidation of human low density lipoprotein | Q69611707 | ||
| P433 | issue | 2 | |
| P921 | main subject | macrophage | Q184204 |
| adipocyte | Q357519 | ||
| P304 | page(s) | 259-269 | |
| P577 | publication date | 2002-12-01 | |
| P1433 | published in | Atherosclerosis | Q4813570 |
| P1476 | title | The adipocyte lipid binding protein (ALBP/aP2) gene facilitates foam cell formation in human THP-1 macrophages | |
| P478 | volume | 165 |
| Q55135310 | 9- and 13-HODE regulate fatty acid binding protein-4 in human macrophages, but does not involve HODE/GPR132 axis in PPAR-γ regulation of FABP4. |
| Q34565501 | A genetic variant at the fatty acid-binding protein aP2 locus reduces the risk for hypertriglyceridemia, type 2 diabetes, and cardiovascular disease |
| Q33757446 | A-FABP concentration is more strongly associated with cardiometabolic risk factors and the occurrence of metabolic syndrome in premenopausal than in postmenopausal middle-aged women |
| Q39819315 | Adipocyte fatty acid binding protein in atherosclerotic plaques is associated with local vulnerability and is predictive for the occurrence of adverse cardiovascular events |
| Q38050907 | Adipocyte fatty acid binding protein: a novel adipokine involved in the pathogenesis of metabolic and vascular disease? |
| Q33795966 | Adipocyte fatty acid-binding protein modulates inflammatory responses in macrophages through a positive feedback loop involving c-Jun NH2-terminal kinases and activator protein-1. |
| Q45418600 | Adipocyte-fatty acid binding protein and non-alcoholic fatty liver disease in the elderly |
| Q37074304 | Adipocyte/macrophage fatty acid binding proteins in metabolic syndrome |
| Q39037277 | Adipocyte/macrophage fatty acid-binding proteins contribute to metabolic deterioration through actions in both macrophages and adipocytes in mice |
| Q26852200 | Adipokines as a novel link between obesity and atherosclerosis |
| Q37972596 | Adiponectin and adipocyte fatty acid binding protein in the pathogenesis of cardiovascular disease |
| Q39128457 | Adipose Fatty Acid Binding Protein Promotes Saturated Fatty Acid-Induced Macrophage Cell Death through Enhancing Ceramide Production |
| Q50196606 | Adipose inflammation at the heart of vascular disease. |
| Q64113748 | Associations between Fatty Acid-Binding Protein 4⁻A Proinflammatory Adipokine and Insulin Resistance, Gestational and Type 2 Diabetes Mellitus |
| Q45344178 | Calcium-dependent release of adipocyte fatty acid binding protein from human adipocytes |
| Q46597595 | Cholesterol regulation of genes involved in sterol trafficking in human THP-1 macrophages |
| Q37301876 | Circulating FABP4 and FABP5 levels are differently linked to OSA severity and treatment |
| Q48362646 | Circulating adipocyte fatty acid-binding protein levels are independently associated with heart failure |
| Q33635135 | Combined adipocyte-macrophage fatty acid-binding protein deficiency improves metabolism, atherosclerosis, and survival in apolipoprotein E-deficient mice. |
| Q47227057 | Cord Blood Adipocyte Fatty Acid-Binding Protein Levels Correlate With Gestational Age and Birth Weight in Neonates |
| Q28652149 | Cyclooxygenase-1 as the main source of proinflammatory factors after sodium orthovanadate treatment |
| Q42176712 | Cytoprotective role of the fatty acid binding protein 4 against oxidative and endoplasmic reticulum stress in 3T3-L1 adipocytes |
| Q47241282 | DBZ blocks LPS-induced monocyte activation and foam cell formation via inhibiting nuclear factor-ĸB. |
| Q34551915 | Enhanced insulin sensitivity, energy expenditure and thermogenesis in adipose-specific Pten suppression in mice |
| Q84484303 | Expression and regulation of adipocyte fatty acid binding protein in granulosa cells and its relation with clinical characteristics of polycystic ovary syndrome |
| Q43257855 | FABP4: a novel candidate gene for polycystic ovary syndrome |
| Q36902746 | Fat cell-derived modulators of vascular cell pathophysiology: the list keeps growing |
| Q35042217 | Fatty Acid-Binding Protein 4 (FABP4): Pathophysiological Insights and Potent Clinical Biomarker of Metabolic and Cardiovascular Diseases |
| Q64079418 | Fatty Acid-Binding Protein 4 in Cardiovascular and Metabolic Diseases |
| Q47740112 | Fatty acid binding protein-4 is associated with disability in multiple sclerosis patients |
| Q35873155 | Fatty acid binding proteins--the evolutionary crossroads of inflammatory and metabolic responses. |
| Q48113929 | Fatty acid-binding protein 4 predicts gestational hypertension and preeclampsia in women with gestational diabetes mellitus |
| Q33649348 | Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets |
| Q33694863 | Fatty-acid binding protein 4 gene variants and childhood obesity: potential implications for insulin sensitivity and CRP levels |
| Q36325637 | Gene Expression and Correlation of Pten and Fabp4 in Liver, Muscle, and Adipose Tissues of Type 2 Diabetes Rats. |
| Q38946503 | Hydroxyoctadecadienoic acids regulate apoptosis in human THP-1 cells in a PPARγ-dependent manner. |
| Q41902518 | Hydroxyoctadecadienoic acids: novel regulators of macrophage differentiation and atherogenesis |
| Q30884393 | Identification of novel PTEN-binding partners: PTEN interaction with fatty acid binding protein FABP4. |
| Q61945778 | Inhibition of phospholipase A2 activity by conjugated linoleic acids in human macrophages |
| Q55023430 | Intermittent High Glucose Exacerbates A-FABP Activation and Inflammatory Response through TLR4-JNK Signaling in THP-1 Cells. |
| Q38071250 | Interplay between adipose tissue and blood vessels in obesity and vascular dysfunction |
| Q36635274 | Lessons on conditional gene targeting in mouse adipose tissue |
| Q38908903 | Lipid chaperones and metabolic inflammation |
| Q93271452 | Macrophage FABP4 is required for neutrophil recruitment and bacterial clearance in Pseudomonas aeruginosa pneumonia |
| Q38161454 | Mechanism and clinical evidence of lipocalin-2 and adipocyte fatty acid-binding protein linking obesity and atherosclerosis |
| Q30441275 | Mechanisms by which diabetes increases cardiovascular disease |
| Q26799705 | Metabolic functions of FABPs--mechanisms and therapeutic implications |
| Q58710194 | Molecular Dynamics Exploration of Selectivity of Dual Inhibitors 5M7, 65X, and 65Z toward Fatty Acid Binding Proteins 4 and 5 |
| Q38075862 | Molecular mechanisms of hypolipidemic effects of curcumin |
| Q35355559 | Oxidized low-density lipoprotein suppresses expression of prostaglandin E receptor subtype EP3 in human THP-1 macrophages |
| Q35539448 | Peroxisome proliferator-activated receptors: new targets for the pharmacological modulation of macrophage gene expression and function |
| Q39408922 | Plasma Levels of Fatty Acid-Binding Protein 4, Retinol-Binding Protein 4, High-Molecular-Weight Adiponectin, and Cardiovascular Mortality Among Men With Type 2 Diabetes: A 22-Year Prospective Study |
| Q38825692 | Pycnogenol attenuates atherosclerosis by regulating lipid metabolism through the TLR4-NF-κB pathway |
| Q39588885 | Receptor mediated elevation in FABP4 levels by advanced glycation end products induces cholesterol and triacylglycerol accumulation in THP-1 macrophages |
| Q37989491 | Regulation of gene expression in atherosclerosis: insights from microarray studies in monocytes/macrophages |
| Q39453989 | Regulatory effects of curcumin on lipid accumulation in monocytes/macrophages |
| Q35859743 | Small lipid-binding proteins in regulating endothelial and vascular functions: focusing on adipocyte fatty acid binding protein and lipocalin-2. |
| Q50874092 | Tamoxifen inhibits macrophage FABP4 expression through the combined effects of the GR and PPARγ pathways. |
| Q28513582 | The fatty acid-binding protein, aP2, coordinates macrophage cholesterol trafficking and inflammatory activity. Macrophage expression of aP2 impacts peroxisome proliferator-activated receptor gamma and IkappaB kinase activities |
| Q28271189 | The role of fatty acid binding proteins in metabolic syndrome and atherosclerosis |
| Q34713714 | Transcriptional control of adipose lipid handling by IRF4 |
| Q28305340 | Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2 |
| Q36825147 | Tribbles Homolog 3 Promotes Foam Cell Formation Associated with Decreased Proinflammatory Cytokine Production in Macrophages: Evidence for Reciprocal Regulation of Cholesterol Uptake and Inflammation |
| Q40624157 | alpha-Melanocyte-stimulating hormone inhibits lipopolysaccharide-induced biological responses by downregulating CD14 from macrophages |
| Q37352012 | mRNA-binding protein ZFP36 is expressed in atherosclerotic lesions and reduces inflammation in aortic endothelial cells |
Search more.